All Work

Chris Lange

What to Expect From Goldman Sachs in Q2

The Goldman Sachs Group, Inc. (NYSE: GS) is scheduled to release its second quarter earnings report before the markets open on Tuesday. Thomson Reuters has consensus estimates calling for $4.66 in earnings per share…

Chris Lange · 8 years ago

Why Tonix Pharmaceuticals Is Winning Big on Monday

Tonix Pharmaceuticals saw its shares make a solid gain to start off the week after the company announced an update from the FDA regarding its Alzheimer’s agitation treatment.

Chris Lange · 8 years ago

Focus Financial Partners Closes in on IPO

Focus Financial Partners expects to price more than 16 million shares to result in an initial public offering valued up to more than $727 million.

Chris Lange · 8 years ago

Friday’s Biggest Winners and Losers in the S&P 500

Friday was a relatively positive day for the broad U.S. markets, with all the major averages closing the week with gains. Crude oil was marginally up to close out the week. The S&P 500…

Chris Lange · 8 years ago

FDA Warns of Potential Hoax Letters

The FDA issued a warning early on Friday that consumers should be on the lookout for criminals forging FDA warning letters.

Chris Lange · 8 years ago

Rising Oil Prices Intimidate Short Sellers

The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected big oil stocks decreased.

Chris Lange · 8 years ago

Where Did Major Pharma Short Sellers Go?

The June 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.

Chris Lange · 8 years ago